Xeris Biopharma (XERS) Q4 2024 Earnings

Nov 8Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.14
-0.12
-0.1
-0.09

Details

Expected EPS
-0.086667
Actual EPS
-0.11
Surprise EPS
-0.02
Surprise Percent
-26.92%

Description

⁨Xeris Biopharma⁩ (⁦XERS⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts